Duopharma aiming for big govt insulin tender


Duopharma group managing director Leonard Ariff Abdul Shatar.

KLANG: Duopharma Biotech Bhd is hoping to secure a sizeable contract to supply insulin to the Health Ministry (MoH) in the near term, which will help propel its growth.

“The significant jump (in contract value) has already occurred based on the announcements we made. I think we’ve announced all the significant jumps that we can foresee (for now).

Follow us on our official WhatsApp channel for breaking news alerts and key updates!

Next In Business News

Sime Darby Property stays positive on hitting RM4bil sales this year
Aquawalk expands regional footprint with RM24.6mil East Java oceanarium JV
Securities Commission wins court order to recover RM5.83mil in insider trading case against former executives
Amtel buys RM23mil Perak land for vehicle manufacturing expansion
Tomei continues strategic monitoring to mitigate risks
PPB Group net profit eases to RM234mil, revenue declines to RM1.29bil in 1Q26
KLCCP Stapled Group 1Q net profit rose to RM204.2mil, declares 9.30 sen dividend
Hengyuan refining rebounds to post 1Q net profit of RM525.5mil
Coraza acquires RM13.5mil Penang industrial property to support expansion
Sunway records higher 1Q26 earnings

Others Also Read